RT Journal Article SR Electronic T1 ACE inhibitors vs ARBs: Is one class better for heart failure? JF Cleveland Clinic Journal of Medicine JO Cleve Clin J Med FD Cleveland Clinic SP 433 OP 438 VO 69 IS 5 A2 James Young A1 Mark E. Dunlap A1 Ross C. Peterson YR 2002 UL http://www.ccjm.org/content/69/5/433.abstract AB Although angiotensin-converting enzyme (ACE) inhibitors decrease mortality in heart failure, they incompletely suppress angiotensin II with long-term therapy. Since angiotensin receptor blockers (ARBs) block the biologic effects of angiotensin II more completely than ACE inhibitors, they could be beneficial in the treatment of heart failure.